Panelists discuss how the Port Delivery System (PDS) presents important considerations around adverse effects, patient ...

Harrow's "Harrow Cares" program, in partnership with Cencora, aims to improve access and affordability of eye care treatments ...

Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the ...

Recipients will be awarded $100,000 to support a collaborative project related to glaucoma ...

The company states LYNX is the world’s first and only pattern scanning laser indirect ophthalmoscope and is battery-powered ...

The investigators found that the premature births to be associated with vascular changes on ocular coherence ...

The AI-READI project aims to establish fair, equitable, and ethical access to big data, enhancing artificial intelligence’s ...

The meetings support the company’s submission for its bioengineered corneal implants to eliminate corneal blindness.

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was ...

The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with ...